Both in Biotechnology
PharmaCyte Biotech vs Liminatus Pharma
Over the past year PMCB returned −57.2% and LIMN returned −95.3%; their daily moves had a correlation of -0.05.
PMCB −57.2% LIMN −95.3%Growth of $1, one year, split-adjusted
| Metric | PMCB | LIMN |
|---|---|---|
| Price | $0.4190 | $3.91 |
| Market cap | $4.5M | $5.3M |
| Today | −0.21% | −8.43% |
| 1 month | −18.6% | −7.6% |
| 6 months | −37.6% | −55.8% |
| Year to date | −42.1% | −87.2% |
| 1 year | −56.8% | −94.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $30.5M | — |
| Dividend yield | — | — |
| Volatility (60d) | 58.7% | 1,154.9% |
| Short % of float | 0.7% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).